ShK-186 in patients with psoriatic arthritis

Trial Profile

ShK-186 in patients with psoriatic arthritis

Planning
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Dalazatide (Primary)
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Sponsors Kineta
  • Most Recent Events

    • 26 Nov 2014 New trial record
    • 14 Oct 2014 This trial is expected to be initiated in the coming months, according to a Kineta media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top